Discover how NR1I2 polymorphism influences clopidogrel response in stroke patients and the future of personalized medicine in stroke treatment.
Explore the fascinating pharmacokinetic studies of human urinary kininogenase (HUK), a promising enzyme treatment for ischemic stroke derived from human urine.